聚力文化(002247.SZ):聚力互盈起訴公司決議撤銷糾紛 法院已受理
格隆匯1月9日丨聚力文化(002247.SZ)公佈,公司於2020年1月8日收到北京市朝陽區人民法院(“法院”)寄來的《商事傳票》、《民事起訴狀》等司法文件,蘇州聚力互盈投資管理中心(有限合夥)(“聚力互盈”)起訴公司決議撤銷糾紛,法院已受理。
案件事由:聚力互盈以公司2019年第二次臨時股東大會決議存在法律瑕疵、損害聚力互盈及相關股東的合法權益為由起訴公司,要求法院撤銷公司2019年第二次臨時股東大會決議。
訴訟請求:聚力互盈請求法院撤銷公司於2019年12月6日作出的2019年第二次臨時股東會決議;訴訟費由公司承擔。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.